Egan Richard, Lawrenson Ross, Kidd Jacquie, Cassim Shemana, Black Stella, Blundell Rawiri, Bateman Jerram, Broughton John R
Department of Preventive & Social Medicine, Te Tari Hauora Tūmatanui, Dunedin School of Medicine, Te Kuri Hauora O Ōtepoti; University of Otago, Te Whare Wānanga O Otago.
Waikato Medical Research Centre, Waikato Hospital Hamilton; Waikato Medical Research Centre, University of Waikato, Hamilton.
N Z Med J. 2020 Sep 4;133(1521):69-76.
Māori experience poorer health statistics in terms of cancer incidence and mortality compared to non-Māori. For prostate cancer, Māori men are less likely than non-Māori men to be diagnosed with prostate cancer, but those that are diagnosed are much more likely to die of the disease than non-Māori men resulting in an excess mortality rate in Māori men compared with non-Māori. A review of the literature included a review of the epidemiology of prostate cancer; of screening; of access to healthcare and of treatment modalities. Our conclusion was that there are a number of reasons for the disparity in outcomes for Māori including differences in staging and characteristics at diagnosis; differences in screening and treatment offered to Māori men; and general barriers to healthcare that exist for Māori men in New Zealand. We conclude that there is a need for more culturally appropriate care to be available to Māori men.
与非毛利人相比，毛利人的癌症发病率和死亡率方面的健康统计数据更差。就前列腺癌而言，毛利男性被诊断出患有前列腺癌的可能性低于非毛利男性，但那些被诊断出的人死于该疾病的可能性比非毛利男性高得多，导致毛利男性的死亡率高于非毛利男性。对文献的回顾包括对前列腺癌的流行病学、筛查、获得医疗保健的机会和治疗方式的回顾。我们的结论是，毛利人在治疗结果上存在差异有多种原因，包括诊断时分期和特征的差异；为毛利男性提供的筛查和治疗的差异；以及新西兰毛利男性在获得医疗保健方面存在的普遍障碍。我们得出结论，需要为毛利男性提供更符合文化习惯的护理。
